You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 125 No. 8, August 1989 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  STUDIES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Evidence for Eosinophil Degranulation in the Pathogenesis of Herpes Gestationis

Andrew J. Scheman, MD; Maria D. Hordinsky, MD; David W. Groth, MD; Gregory M. Vercellotti, MD; Kristin M. Leiferman, MD

Arch Dermatol. 1989;125(8):1079-1083.


Abstract



• Herpes gestationis is a pregnancy-related bullous dermatosis of unknown origin with associated tissue and peripheral blood eosinophilia. In this report, eosinophil degranulation in herpes gestationis was studied, and the role that the eosinophil may have as an effector cell that induces tissue damage through deposition of toxic cationic proteins is discussed. Using indirect immunofluorescence with antibody to human eosinophil granule major basic protein, major basic protein was observed both within tissue eosinophils and deposited extracellularly outside eosinophils in the dermis of eight patients with herpes gestationis. Possible mechanisms whereby eosinophils might be activated to degranulate in herpes gestationis are reviewed.

(Arch Dermatol. 1989;125:1079-1083)



Author Affiliations



From the Departments of Dermatology (Drs Scheman, Hordinsky, and Groth) and Hematology (Dr Vercellotti), University of Minnesota, Minneapolis, and the Department of Dermatology, Mayo Clinic and Mayo Foundation, Rochester, Minn (Dr Leiferman). Dr Scheman is now with the Department of Dermatology, The Johns Hopkins Medical Institutions and Francis Scott Key Medical Center, Baltimore, Md.


Footnotes



Accepted for publication December 29, 1988.

Presented in part at the Society of Investigative Dermatology Meeting, Washington, DC, April 27, 1988.

Reprint requests to Department of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Dr Leiferman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pemphigoid gestationis
Lardenoije et al.
BMJ Case Reports 2011;2011:bcr0120102623-bcr0120102623.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.